DNA Target Binding Insight Solution

About CRISPR QC

CRISPR QC is a private, early-stage company founded in 2016 and based in Cambridge, USA, operating at the intersection of CRISPR tools and diagnostics. The company has developed the CRISPR Analytics Platform™, a first-of-its-kind service that uses a proprietary graphene-based biosensor (CRISPR-Chip™) to provide real-time, quantitative data on the biochemical efficiency of CRISPR-Cas components. This platform is positioned as a critical quality control and optimization tool for researchers and developers, helping to identify inefficiencies early, reduce costly trial-and-error, and accelerate timelines from discovery to commercialization.

Other CRISPR Workflow Optimization Drugs